相关实验视频

Updated: Jun 26, 2026

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT

Published on: January 22, 2018

68Ga-NK224 PET/CT用于PD-L1表达和瘤间异质性的非侵入性评估:一个翻译探索性研究

Liang Zhao¹, Yizhen Pang¹, Yi Ding²

¹First Affiliated Hospital of Xiamen University, Xiamen, China.

Clinical cancer research : an official journal of the American Association for Cancer Research

|May 9, 2025

概括

这项研究引入了68Ga-NK224 PET/CT用于评估非小细胞肺癌中PD-L1表达. 这种新型的放射追踪器准确地可视化瘤异质性,并有助于优化免疫治疗.

科学领域:

核医学就是核医学.
在瘤学瘤学.
放射化学放射化学是指辐射化学.

背景情况:

开发用于向分子成像的基于的新型放射追踪剂.
编程死亡配体1 (PD-L1) 在癌症免疫治疗中的作用以及需要准确的评估方法.

研究的目的:

开发和评估68Ga-NK224,一种针对人类PD-L1.1的新型放射追踪器.
评估68Ga-NK224正子发射断层扫描/计算机断层扫描 (PET/CT) 的可行性,以评估非小细胞肺癌 (NSCLC) 中的PD-L1表达和瘤异质性.

主要方法:

用-68 (68Ga) 对NK224进行放射性标记.
在使用小动物PET,生物分布和阻断研究的瘤模型中进行临床前评估.
临床前性研究涉及37名NSCLC患者接受68Ga-NK224 PET/CT,与PD-L1表达与免疫组织化学 (IHC) 相关联.

主要成果:

在临床前研究中,68Ga-NK224表现出高瘤吸收率,快速清除,以及优异的瘤背景对比度.
临床68Ga-NK224 PET/CT与PD-L1表达 (IHC) 有显著的相关性,但与18F-FDG PET/CT没有显著的相关性.
追踪器有效地可视化了患者内瘤异质性,SUVmax中位数变化系数为27.5%.

结论:

68Ga-NK224 PET/CT是一种可行且耐受良好的成像方式,用于评估NSCLC中的PD-L1表达和瘤异质性.
放射追踪器监测PD-L1占用率的能力为优化免疫治疗剂量策略提供了潜力.

更多相关视频

Development of a 68Gallium-Labeled D-Peptide PET Tracer for Imaging Programmed Death-Ligand 1 Expression

Development of a 68Gallium-Labeled D-Peptide PET Tracer for Imaging Programmed Death-Ligand 1 Expression

Published on: February 3, 2023

Radiosynthesis, Quality Control, and Small Animal Positron Emission Tomography Imaging of 68Ga-Labelled Nano Molecules

Radiosynthesis, Quality Control, and Small Animal Positron Emission Tomography Imaging of ⁶⁸Ga-Labelled Nano Molecules

Published on: October 4, 2024

相关概念视频

Positron Emission Tomography

Positron Emission Tomography

Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body being...

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET